Menu
Currency
GWAS Study

Germline variants at SOHLH2 influence multiple myeloma risk.

Duran-Lozano L, Thorleifsson G, Lopez de Lapuente Portilla A et al.

33875642 PubMed ID
GWAS Study Type
427613 Participants
80 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DL
Duran-Lozano L
TG
Thorleifsson G
LD
Lopez de Lapuente Portilla A
NA
Niroula A
WM
Went M
TM
Thodberg M
PM
Pertesi M
AR
Ajore R
CC
Cafaro C
OP
Olason PI
SL
Stefansdottir L
BW
Bragi Walters G
HG
Halldorsson GH
TI
Turesson I
KM
Kaiser MF
WN
Weinhold N
AN
Abildgaard N
AN
Andersen NF
MU
Mellqvist UH
WA
Waage A
JA
Juul-Vangsted A
TU
Thorsteinsdottir U
HM
Hansson M
HR
Houlston R
RT
Rafnar T
SK
Stefansson K
NB
Nilsson B
Chapter II

Abstract

Summary of the research findings

Multiple myeloma (MM) is caused by the uncontrolled, clonal expansion of plasma cells. While there is epidemiological evidence for inherited susceptibility, the molecular basis remains incompletely understood. We report a genome-wide association study totalling 5,320 cases and 422,289 controls from four Nordic populations, and find a novel MM risk variant at SOHLH2 at 13q13.3 (risk allele frequency = 3.5%; odds ratio = 1.38; P = 2.2 × 10-14). This gene encodes a transcription factor involved in gametogenesis that is normally only weakly expressed in plasma cells. The association is represented by 14 variants in linkage disequilibrium. Among these, rs75712673 maps to a genomic region with open chromatin in plasma cells, and upregulates SOHLH2 in this cell type. Moreover, rs75712673 influences transcriptional activity in luciferase assays, and shows a chromatin looping interaction with the SOHLH2 promoter. Our work provides novel insight into MM susceptibility.

4,376 European ancestry multiple myeloma cases, 944 European ancestry monoclonal gammopathy of undetermined significance cases, 422,293 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

427613
Total Participants
GWAS
Study Type
Yes
Replicated
5,598 European ancestry cases, 15,261 European ancestry controls
Replication Participants
European
Ancestry
Denmark, Iceland, Norway, Sweden, Netherlands, Germany, U.K., U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.